CRBU EPS Estimates
Caribou Biosciences, Inc.
$0.41
-$0.01(-2.24%)
38
Overall
60
Value
18
Tech
36
Quality
Market Cap
$44.34M
Volume
1.63M
52W Range
$0.40 - $2.49
Target Price
$5.60
CRBU EPS estimates: the consensus estimate for Caribou Biosciences, Inc.'s current fiscal year is -$1.07 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRBU EPS Estimates
- EPS estimate, current quarter
- $-0.29
- EPS estimate, next quarter
- $-0.11
- EPS estimate, current year
- $-1.07
- EPS estimate, next year
- $-0.73
- EPS growth, 3-year
- +7.87%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.59 |
| 2024 | $-1.65 |
| 2023 | $-1.38 |
| 2022 | $-1.64 |
| 2021 | $-2.11 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRBU | $0.41 | -2.2% | 1.63M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Caribou Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW